Research Article

A  Phase IV Study of the Safety and Efficacy of CinnoPar® in Iranian Patients with Osteoporosis

Table 3

Comparison of some of the AEs with other studies (in percent).

Our studyNeer et al.KendlerLangdahl et al.Saag et al.Hadji et al.Obermayer‐Pietsch et al.

Hypercalcemia411445
Nausea354
Headache1387
Dizziness19475
Pain32
Rash11
Insomnia15
Muscle spasms149
Dyspepsia133
Vomiting13
Spinal fracture11